Myriad Genetics (MYGN)
Myriad Genetics Cash Investing: -43.82M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
MYGN Cash Investing Rankings
| Overall | 25th percentile | 3216 of 4331 |
| Sector | 22nd percentile | 650 of 840 in Services |
| Industry | 9th percentile | 10 of 11 in Research Services |
MYGN Cash Investing Range, Past 5 Years
| Minimum | -101.14M | Dec 2008 |
| Maximum | 42.48M | Mar 2011 |
| Average | -22.89M |
About Cash Investing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More
You may also be interested in these MYGN related companies
MYGN News
Teva Pharmaceutical Inds, VeriFone Systems Among Stocks Down on Above-average Volume Tuesday
May 29, 4:34PM Fox Business
May 29, 4:34PM Fox Business
NEW POST: "A Bit Too Rare" http://stks.co/3ySS $GENE $GHDX $MYGN $QQQ $ROSG $SPY
about 7 days ago by chessNwine
about 7 days ago by chessNwine
Auriga Maintains a 'Buy' on Myriad Genetics (MYGN); Understanding Two Areas of Concern
May 22, 10:59AM Street Insider
May 22, 10:59AM Street Insider
Leerink Swann Upgrades Myriad Genetics (MYGN) to Outperform; Growth Prospects Good, Risks Overdone
May 21, 7:57AM Street Insider
May 21, 7:57AM Street Insider
Myriad Genetics Raised To Outperform From Mkt Perform By Leerink Swann > $MYGN
about 10 days ago by johnkelly
about 10 days ago by johnkelly
Myriad Genetics' CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)
May 18, 8:42PM Seeking Alpha
May 18, 8:42PM Seeking Alpha
Myriad Genetics Announces Presentation of Lung Cancer Study at American Society for Clinical Oncology Annual Meeting
May 16, 6:05PM GlobeNewswire
May 16, 6:05PM GlobeNewswire
$MYGN http://stks.co/3qZI Holding the 25.50 area nicely, RS making new highs
about 15 days ago by redman59
about 15 days ago by redman59
Myriad Genetics to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
May 02, 4:15PM GlobeNewswire
May 02, 4:15PM GlobeNewswire
Auriga Reiterates a 'Buy' on Myriad Genetics (MYGN); Raising PT on Strong Results
May 02, 2:04PM Street Insider
May 02, 2:04PM Street Insider
Myriad Genetics' CEO Discusses Q1 2012 Results - Earnings Call Transcript
May 01, 10:27PM Seeking Alpha
May 01, 10:27PM Seeking Alpha
Listen to $MYGN Q3 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3bvO
about 29 days ago by earningscast
about 29 days ago by earningscast
$MYGN on IBD Buy List today and outperform rating at Cowen. Look for it to do well at earnings on May 1.
about 40 days ago by abubnic
about 40 days ago by abubnic
$MYGN forms bullish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/3Kdq
about 48 days ago by RecogniaEvents
about 48 days ago by RecogniaEvents
Myriad Genetics to Announce Fiscal 2012 Third Quarter Results on Tuesday, May 1, 2012
Apr 10, 4:15PM GlobeNewswire
Apr 10, 4:15PM GlobeNewswire
Here is what the analysts (sigh) think of the $MYGN patent situation after the SCOTUS ruling yesterday. http://stks.co/36mT
about 64 days ago by bradloncar
about 64 days ago by bradloncar
$MYGN made the Investment Business Daily list of institutional buyers today.
about 65 days ago by abubnic
about 65 days ago by abubnic
Stock moving in and out of #MagicFormulaInvesting this week include $WCRX $WNR $MYGN and others http://stks.co/33iU
about 67 days ago by MagicDiligence
about 67 days ago by MagicDiligence
Looking at the weekly options tables, seems investors were buying insurance on $MYGN after Prometheus. Probably smart, just in case.
about 67 days ago by bradloncar
about 67 days ago by bradloncar
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| MYGN | 24.98 | -0.22 | -0.87% | 2.124B |
| MYF | 15.96 | -0.14 | -0.87% | |
| MYC | 16.30 | +0.01 | +0.06% | |
| MY | 1.38 | -0.14 | -9.21% | 190.00M |
| MXWL | 6.46 | -0.60 | -8.50% | 199.16M |
| MXT | 1.15 | -0.03 | -2.54% | 40.67M |
| MVIS | 1.91 | -0.68 | -26.25% | 44.08M |
| MVG | 8.07 | +0.10 | +1.25% | 443.69M |
| MVC | 12.45 | +0.02 | +0.16% | 298.20M |
| MUX | 2.45 | -0.09 | -3.54% | 399.77M |
